Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
Authors
Keywords
Exenatide, Glycemic variations, Insulin doses, Type 2 diabetes
Journal
Diabetes Therapy
Volume 8, Issue 1, Pages 177-187
Publisher
Springer Nature
Online
2016-12-19
DOI
10.1007/s13300-016-0222-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program
- (2016) Hui Peng et al. Current Diabetes Reports
- Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk
- (2016) DIABETES CARE
- Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
- (2016) A. Dutour et al. DIABETES OBESITY & METABOLISM
- The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population
- (2016) Qiang Zhou et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin Regimen
- (2016) Marie L. Davies et al. PHARMACOTHERAPY
- Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial
- (2016) Shaoyong Xu et al. Trials
- The Efficacy and Tolerability of Exenatide in Comparison to Placebo; A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2016) Shekoufeh Nikfar et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians
- (2015) Daisuke Yabe et al. Current Diabetes Reports
- Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes
- (2015) Chia-Hung Lin et al. Scientific Reports
- Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists
- (2015) Annachiara Uccellatore et al. Diabetes Therapy
- Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists
- (2015) Annachiara Uccellatore et al. Diabetes Therapy
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Ethnic-Specific Obesity Cutoffs for Diabetes Risk: Cross-sectional Study of 490,288 UK Biobank Participants
- (2014) Uduakobong E. Ntuk et al. DIABETES CARE
- Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis
- (2014) Y. G. Kim et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
- (2014) Conrad Eng et al. LANCET
- Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
- (2013) John B. Buse et al. ANNALS OF INTERNAL MEDICINE
- ProAct Study: New Features of Insulin Pumps Improve Diabetes Management and Glycemic Control in Patients after Transition of Continuous Subcutaneous Insulin Infusion Systems
- (2013) Ralph Ziegler et al. Diabetes Technology & Therapeutics
- Efficacy, Safety, and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus: An Integrated Analysis of the DURATION Trials
- (2013) Michael Grimm et al. POSTGRADUATE MEDICINE
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Exenatide Improves Glycemic Variability Assessed by Continuous Glucose Monitoring in Subjects with Type 2 Diabetes
- (2011) Concetta Irace et al. Diabetes Technology & Therapeutics
- Effect of Exenatide on Inflammatory and Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus
- (2011) Jin-dan Wu et al. Diabetes Technology & Therapeutics
- The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review
- (2011) Vanita R. Aroda et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Pharmacological management of type 2 diabetes: the potential of incretin-based therapies
- (2010) B. Charbonnel et al. DIABETES OBESITY & METABOLISM
- Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes
- (2010) A. H. Barnett et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes
- (2010) Walid K.H. Fakhoury et al. PHARMACOLOGY
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- Intensive insulin therapy in newly diagnosed type 2 diabetes
- (2008) Ravi Retnakaran et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now